Subject Numbers Regarding Health Provider Authorizations
Authorization No. 192799-5W
August 9, 2017
Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised his authority to temporarily suspend Dr. Nkanga Utuk Nkanga’s authorization to treat injured workers within the New York State workers’ compensation system effective August 7, 2017. Dr. Nkanga's last known business address is:
78-80 Cromwell Avenue
Staten Island, NY 10304
The Chair’s designee’s investigation has revealed that the New York State Department of Health, State Board for Professional Medical Conduct (BPMC) has issued Order #17-185, wherein Dr. Nkanga may practice medicine only when monitored by a licensed physician, board certified in an appropriate specialty, he must keep a controlled substances log, and he must successfully complete a continuing education program in an area specified by the Office of Professional Medical Conduct. Further investigation has revealed that, pursuant to expert peer review, in or around the time period of 2011 – 2015 Dr. Nkanga was found to have deviated from the standard of care to a moderate and/or severe degree in his treatment of six patients in that his documentation and progress notes were inadequate, and his urine drug screens were not in accordance with applicable standards for patients receiving Suboxone treatment.
Therefore, the Chair believes that Dr. Nkanga may be guilty of misconduct, and that such misconduct would detrimentally affect the quality of care provided to injured workers.
Dr. Nkanga is prohibited from rendering treatment and care to injured workers while his authorization is temporarily suspended. Reports submitted by Dr. Nkanga for services rendered prior to August 7, 2017 are valid, but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Nkanga for services rendered prior to August 7, 2017, should not be denied due to the suspension of his authorization.
This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director’s Office at (800) 781-2362.
Kenneth J. Munnelly
Chair